Note 15 - Net Loss Per Share - Schedule of Antidilutive Securities (Details) - shares shares in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|
| Antidilutive Securities (in shares) | 14,266 | 2,968 | 14,266 | 2,968 |
| Share-Based Payment Arrangement, Option [Member] | ||||
| Antidilutive Securities (in shares) | 185 | 254 | 185 | 254 |
| Restricted Stock [Member] | ||||
| Antidilutive Securities (in shares) | 1,034 | 1,474 | 1,034 | 1,474 |
| Warrant [Member] | ||||
| Antidilutive Securities (in shares) | 13,047 | 1,240 | 13,047 | 1,240 |
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|